Trials / Unknown
UnknownNCT01828892
Glue Application in the Treatment of Low-Output Fistulas
A Randomized Controlled Trial to Evaluate Fibrin Glue Application in the Treatment of Low-Output Enterocutaneous Fistulas
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Jinling Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Adjuvant use of fibrin glue (FG) in the fistula tract has been shown to promote closure of low-output enterocutaneous fistulas (ECFs). The primary objectives of this study are to compare the clinical efficacy, safety of autologous platelet-rich fibrin glue (PRFG), commercial fibrin glue, and control therapy in the management of patients with low-output volume ECFs.
Detailed description
* This is a prospective, randomized, multi-centered study clinical, safety and economic outcome of ECFs patients. * Subjects are randomized to one of 3 groups: * Group 1: Autologous PRFG-treatment \[PRFG + Standard of care (SOC)\] * Group 2: Commercial FG-treatment \[FG + Standard of care (SOC)\] * Group 3: Control (SOC only) * Study will include three phases: * Phase 1: Screening, consent and enrollment * Phase 2: Patients will receive either PRFG, commercial FG, or SOC only for 14 days * Phase 3: Follow up: for patients with closed fistula within 14 days, we will follow up them for 6 months. For patients whose fistulas were still open will be treated with other therapeutic option and follow up for 6 months after closure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endoscopy exploration and glue application | A forward-viewing fistula-fiberscope (EndoView, Outai Medical Equipment, Shanghai, China), with 15cm length and 5mm width of fiber optical wire, was inserted into the fistula tract to accomplish endoscopic visualization. Briefly, the fistula-fiberscope assisted procedure was carried out percutaneously, allowing the exposure of internal hole and the whole tracts, followed by insertion of this catheter with distal mixing device. |
| PROCEDURE | Endoscopy exploration | A forward-viewing fistula-fiberscope (EndoView, Outai Medical Equipment, Shanghai, China), with 15cm length and 5mm width of fiber optical wire, was inserted into the fistula tract to accomplish endoscopic visualization. |
| DRUG | Antibiotics (ceftazidime, cefotaxime, or meropenem, with or without vancomycin) | Antibacterial therapy in patients with signs of systemic sepsis or local inflammation with pain |
| DIETARY_SUPPLEMENT | Nutrition support | Nutritional replacement and bowel rest via enteral or parenteral nutrition |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2017-06-01
- Completion
- 2017-12-01
- First posted
- 2013-04-11
- Last updated
- 2015-06-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01828892. Inclusion in this directory is not an endorsement.